Functional disabilities profile of Chinese elderly people with Alzheimer's disease - A validation study on the Chinese version of the disability assessment for dementia

Dementia and Geriatric Cognitive Disorders

Volumn 20, Issue 2-3, 2005, Pages 112-119

  Mok, Cycbie C M ^a   Siu, Andrew M H ^b   Chan, W C ^a   Yeung, K M ^c   Pan, P C ^d   Li, Siu Wah ^a  

^a CASTLE PEAK HOSPITAL   (Hong Kong)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^c PRINCESS MARGARET HOSPITAL   (Hong Kong)

^d UNITED CHRISTIAN HOSPITAL   (Hong Kong)

Author keywords

Alzheimer's disease; Disability Assessment for Dementia; Functional disabilities

Indexed keywords

ADL DISABILITY; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ARTICLE; BARTHEL INDEX; CHINESE; CORRELATION ANALYSIS; CULTURAL FACTOR; DAILY LIFE ACTIVITY; DISABILITY ASSESSMENT FOR DEMENTIA; FEMALE; FUNCTIONAL DISEASE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; SOCIETY; VALIDATION PROCESS;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHINA; DEMENTIA; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; SOCIOECONOMIC FACTORS;

EID: 23944525084     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086612     Document Type: Article

References (35)

1. US Department of Health and Human Services: Early Alzheimer's disease: Recognition and assessment. AHCPR Publication No 97-R123. Agency for Health Care Policy and Research, 1996.
2. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MMB, Copeland JRM, Dartigues J-F, Jagger C, Martinez-Lage J, Soininen H, Hofman A: Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurology 2000;54(suppl 5):S4-S9.
3. Chiu HFK, Lam LCW, Chi I, Leung T, Li SW, Law WT, Chung DWS, Fung HHL, Kan PS, Lum CM, Ng J, Lau J: Prevalence of dementia in Chinese elderly in Hong Kong. Neurology 1998;50:1002-1009.
4. Hong Kong Census and Statistics Department: Hong Kong in Figures. Hong Kong, HKSAR, 2002.
5. Clarke M, Jagger C, Anderson J, Battcock T, Kelly F, Stern MC: The prevalence of dementia in a total population: A comparison of two screening instruments. Age Ageing 1991;20:396-403.
6. Borell L: Supporting functional behavior in Alzheimer's disease. Int Psychogeriatr 1996;8(suppl 1):123-125.
7. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, ed 4. Washington, American Psychiatric Association, 1994.
8. Burns A, Lawlor B, Craig S: Assessment Scales in Old Age Psychiatry. London, Dunitz, 1999.
9. Kempen GIJM, Suurmeijer TPBM: The development of a hierarchical polychotomous ADL-IADL scale for non-institutionalized elders. Gerontologist 1990;30:497-502.
10. Barberger-Gateau P, Fabrigoule C, Helmer C, Rouch I, Dartigues J-F: Functional impairment in instrumental activities of daily living: An early clinical sign of dementia? J Am Geriatr Soc 1999;47:456-462.
11. Carswell A, Spiegel R: Functional assessment; in Wilcock GA, Bucks RS, Rockwood K (eds): Diagnosis and Management of Dementia: A Manual for Memory Disorders Teams. New York, Oxford University Press, 1999, pp 158-178.
12. Lawton MP, Brody EM: Assessment of older people: Self-maintaining and Instrumental Activities of Daily Living. Gerontologist 1969;9:179-186.
13. Gelinas I, Gauthier L. McIntyre M, Gauthier S: Development of a functional measure for persons with Alzheimer's disease: The Disability Assessment for Dementia. Am J Occup Ther 1999;53:471-481.
14. Morris JC, Cyrus PA, Orazem J, Mas JBS, Bieber F, Ruzicka BB, Gulanski B: Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease. Neurology 1998;50:1222-1230.
15. Dubois B, McKeith I, Orgogozo J-M, Collins O, Meulien D: A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: The Malt Study. Int Psychogeriatr 1999;14:973-982.
16. Raskind MA, Cyrus PA, Ruzicka BB, Gulanski BI: The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. J Clin Psychiatry 1999;60:318-325.
17. Farlow MR, Cyrus PA: Metrifonate therapy in Alzheimer's disease: A pooled analysis of four randomized, double-blind, placebo-controlled trials. Dement Geriatr Cogn Disord 2000;11:202-211.
18. Gelinas I, Gauthier S, Cyrus PA: Metrifonate enhances the ability of Alzheimer's disease patients to initiate, organize, and execute instrumental and basic activities of daily living. J Geriatr Psychiatry Neurol 2000;13:9-16.
19. Raskind MA, Peskind ER, Wessel T, Yuan W, the Galantamine USA-Study Group: Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. Neurology 2000;54:2261-2268.
20. Wilcock GK, Lilenfeld S, Gaens E: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomized controlled trial. Br Med J 2000; 321:145-149.
21. Feldman H, Sauter A, Donald A, Gelinas I, Gauthier S, Torfs K, Parys W, Mehnert A: A 12-month study of functional ability in mild to moderate severity Alzheimer disease. Alzheimer Dis Assoc Disord 2001;15:89-95.
22. Sibley A, MacKnight C, Rockwood K, Fisk J, Gauthier S, Guzman DA, Hogan DB: The effect of the living situation on the severity of dementia at diagnosis. Dement Geriatr Cogn Disord 2002;13:40-45.
23. Chiu H, Lee HC, Chung WS, Kwong PK: Reliability and validity of the Cantonese version of Mini Mental State Examination - A preliminary study. J Hong Kong Coll Psychiatrists 1994, pp 425-428.
24. Reisberg B, Ferris SH, De Leon MJ, Crook T: The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.
25. Shah S, Vanclay F, Cooper B: Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol 1989;44:703-709.
26. Sclan SG, Reisberg B: Functional assessment (FAST) in Alzheimer's disease: Reliability, validity and ordinality. Int Psychogeriatr 1992;4:55-69.
27. Green CR, Mohs RC, Schmeidler J, et al: Functional decline in Alzheimer's disease: A longitudinal study. J Am Geriatr Soc 1993;41:654-661.
28. Galasko D, Edland SD, Morris JC, Clark C, Mohs R, Koss E: The consortium to establish a registry for Alzheimer's disease (CERAD). Neurology 1995;45:1451-1455.
29. Mahurin RK, DeBettignies BH, Pirozzolo FJ: Structured assessment of independent living skills: Preliminary report of a performance measure of functional abilities in dementia. J Gerontol 1991;46:58-66.
30. Oakley F, Sunderland T, Hill JL, Phillips SL, Makahon R, Ebner JD: The Daily Activities Questionnaire: A functional assessment for people with Alzheimer's disease. Phys Occup Ther Geriatr 1991;10:67-81.
31. Carswell A, Eastwood R: Activities of daily living, cognitive impairment and social function in community residents with Alzheimer's disease. Can J Occup Ther 1993;60:130-136.
32. Beland F, Aunzunegui MV: Predictors of functional status in older people living at home. Age Ageing 1999;28:153-159.
33. Hebert R, Brayne C, Spiegelhalter D: Factors associated with functional decline and improvement in a very elderly community-dwelling population. Am J Epidemiol 1999;159: 501-510.
34. Sisson RA: Cognitive status as a predictor of right hemisphere stroke outcomes. J Neurosci Nurs 1995;27:152-156.
35. Gauthier L, Gauthier S: Assessment of functional changes in Alzheimer's disease. Neuroepidemiology 1990;9:183-188.